To describe the natural history of predominantly mild rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and evaluate imaging markers over 2 years, highlighting their clinical significance.
Key Findings:
Pulmonary function and quantitative CT measures remained stable over 24 months, despite an 8% mortality rate, which is noteworthy as deaths were not preceded by measurable decline in FVC or imaging parameters.
80% of participants had pulmonary fibrosis, but only 20% classified as definite or probable usual interstitial pneumonia.
Interpretation:
The findings challenge the conventional paradigm in ILD where functional decline typically precedes death, suggesting a need for further investigation into the clinical implications of these results.
Limitations:
Modest sample size and missing follow-up data due to the COVID-19 pandemic, which may affect the generalizability of the findings.
Limited mortality events constrain definitive conclusions about prognostic performance.
Conclusion:
The study highlights the stability of pulmonary function in RA-ILD over 24 months despite mortality, warranting further research to explore the underlying mechanisms.
